LINALIGLIP DAPAMET 1000 (Linagliptin 5mg, Dapagliflozin 10mg and Metformin Hydrochloride SR 1000mg) – Steris Healthcare

What is LINALIGLIP DAPAMET 1000 For?

LINALIGLIP DAPAMET 1000 is built around a fixed-dose combination of Linagliptin 5mg, Dapagliflozin 10mg, and Metformin Hydrochloride (SR) 1000mg — a higher-strength metformin variant compared to standard combination tablets. It is prescribed for adults with Type 2 diabetes mellitus who are already on metformin-based therapy and require intensification without adding pill count, particularly those needing the full 1000mg metformin dose alongside incretin and SGLT2-pathway support. The sustained-release (SR) metformin component allows for gradual absorption, helping reduce the gastrointestinal side effects often associated with immediate-release metformin at higher doses. Manufactured under WHO-GMP and ISO 9001:2018 certified conditions by Steris Healthcare, LINALIGLIP DAPAMET 1000 offers dependable potency for consistent, once-daily glycemic management.

Why It's Important

As Type 2 diabetes progresses, many patients need higher doses of metformin combined with additional agents to maintain target HbA1c levels. Using separate tablets for each component increases pill burden and can hurt adherence, especially in patients already managing multiple comorbidities. LINALIGLIP DAPAMET 1000 is important because it consolidates a clinically meaningful, higher-strength triple therapy into one convenient tablet, supporting better long-term glucose control while its SR technology helps improve gastrointestinal tolerability — a common reason patients discontinue metformin therapy at higher doses.

Key Benefits of Linagliptin 5mg, Dapagliflozin 10mg and Metformin Hydrochloride (SR) 1000mg

What Are the Benefits?

  • Delivers intensified glycemic control through three complementary mechanisms in one tablet
  • Sustained-release metformin technology reduces GI side effects versus immediate-release formulations
  • Once-daily dosing convenience supports better long-term adherence
  • Dapagliflozin component adds cardiovascular and renal protective benefits
  • Linagliptin's biliary excretion profile makes it suitable even with mild-moderate renal impairment
  • Manufactured with strict quality assurance by Steris Healthcare

Mechanism of Action

This combination acts through three complementary pathways. Metformin (SR) reduces hepatic glucose production and improves peripheral insulin sensitivity, with its sustained-release matrix ensuring gradual absorption and steadier plasma levels throughout the day. Linagliptin, a DPP-4 inhibitor, prevents breakdown of incretin hormones GLP-1 and GIP, enhancing glucose-dependent insulin secretion while suppressing excess glucagon release. Dapagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption at the renal proximal tubule, promoting urinary glucose excretion independent of insulin. Together, this triple mechanism addresses hepatic, incretin-based, and renal glucose handling, offering a more complete and sustained approach to blood sugar control than metformin alone.

Side Effects

Commonly reported side effects of LINALIGLIP DAPAMET 1000 include:

  • Mild gastrointestinal discomfort or nausea
  • Increased urinary frequency
  • Genital or urinary tract infections
  • Headache
  • Mild dizziness

Serious Side Effects Of LINALIGLIP DAPAMET 1000

Seek immediate medical attention if you notice:

  • Signs of lactic acidosis (unusual muscle pain, difficulty breathing, extreme fatigue)
  • Symptoms of diabetic ketoacidosis, even with normal blood glucose levels (nausea, vomiting, abdominal pain)
  • Signs of dehydration or a significant drop in blood pressure
  • Severe urinary tract or genital fungal infection
  • Signs of hypoglycemia, especially when combined with other antidiabetic agents
  • Severe allergic reaction (rash, swelling, difficulty breathing)

Available Substitute For LINALIGLIP DAPAMET 1000

Patients unable to access LINALIGLIP DAPAMET 1000 may be prescribed other Linagliptin + Dapagliflozin + Metformin SR 1000mg combination brands available in the market, based on their physician's advice, since the release profile and excipient quality of SR formulations can vary between manufacturers. Any brand substitution should be made under medical supervision, with continued monitoring of renal function and glycemic parameters regardless of brand.

Dosage Guidelines For LINALIGLIP DAPAMET 1000

Population    Recommended DoseFrequency
Adults1 tablet    Once daily, preferably with dinner
Renal-impaired     Dose adjustment requiredAs advised by physician
ElderlyAs advised by physicianIndividualised

Tablets should be swallowed whole with food and not crushed or chewed, as this disrupts the sustained-release mechanism. Take strictly as directed by a registered medical practitioner, with adequate hydration recommended.

Precautions & Warnings

  • Avoid use in patients with known hypersensitivity to any of the three components
  • Contraindicated in severe renal impairment, metabolic acidosis, or diabetic ketoacidosis
  • Discontinue before contrast-imaging procedures or major surgery, as advised by physician, due to lactic acidosis risk
  • Do not crush, split, or chew the SR tablet
  • Increases risk of genital and urinary tract infections; maintain good hygiene
  • Use caution in patients prone to volume depletion or on diuretic therapy
  • Not recommended during pregnancy or breastfeeding
  • Regular monitoring of renal function and HbA1c is advised
  • Keep out of reach of children

Conclusion

LINALIGLIP DAPAMET 1000 (Linagliptin 5mg, Dapagliflozin 10mg and Metformin Hydrochloride SR 1000mg) from Steris Healthcare offers a higher-strength, once-daily triple-mechanism solution for Type 2 diabetes patients needing intensified glycemic control with improved gastrointestinal tolerability. Backed by WHO-GMP manufacturing standards, it stands as a reliable choice for physicians managing patients on advanced combination diabetes therapy.

Comments

Post a Comment

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

 Healthcare is one of the most significant sectors influencing the well-being of individuals and communities. As medical science advances, the demand for reliable pharmaceutical products continues to grow. Patients, healthcare professionals, and medical institutions all depend on high-quality medicines that meet strict standards of safety and effectiveness. Pharmaceutical companies play a vital role in ensuring these products are developed, manufactured, and delivered responsibly. Steris Healthcare is committed to supporting better healthcare by providing quality pharmaceutical products designed to improve patient outcomes. Guided by innovation, integrity, and continuous improvement, the company strives to meet the evolving needs of the healthcare industry while maintaining high standards of quality and customer satisfaction. A Vision for Better Healthcare Every successful healthcare organization begins with a clear vision. Steris Healthcare believes that quality medicines and de...
Read more

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness

Image
  N-Acetyl L-Cysteine (NAC), Pine Bark Extract & Resveratrol Tablets: Ingredients and Health Benefits Today’s lifestyle in India has changed a lot. Long working hours, stress, pollution, processed food, and lack of physical activity are affecting overall health. Many people feel tired, low on energy, or struggle with metabolic and hormonal balance tablet . One of the main reasons behind this is oxidative stress. Oxidative stress happens when harmful molecules called free radicals damage the body’s cells. Over time, this may affect immunity, liver health, heart health, skin, and overall wellness.  STYLECYSTIN ENDO is a specially designed antioxidant tablet that contains N-Acetyl L-Cysteine (NAC), Pine Bark Extract, and Resveratrol . This powerful combination supports cellular protection, improves antioxidant levels, and promotes better internal balance. It is commonly recommended as supportive therapy in metabolic conditions, women’s health concerns, and lifestyle-related ...
Read more
Megestrol Acetate 160 mg: MAGRAL 160 Uses, Benefits & Safety MAGRAL 160 contains Megestrol Acetate 160 mg and is marketed by Steris Healthcare . Megestrol acetate is a synthetic progestin that is used in specific clinical situations, particularly for managing anorexia, cachexia, or significant unexplained weight loss associated with advanced cancer or AIDS , depending on the approved indication and medical judgment. It is a prescription medicine and should be used under the supervision of a qualified healthcare professional. Megestrol acetate is not a general-purpose appetite booster or routine weight-gain medicine. Before treatment, the underlying reason for poor appetite or weight loss should be evaluated. What is MAGRAL 160 For? MAGRAL 160 may be prescribed when significant appetite loss or involuntary weight loss occurs in certain serious medical conditions. Megestrol acetate can help increase appetite and may contribute to weight gain in appropriately selected patients. Th...
Read more